openPR Logo
Press release

Autoimmune Disease Therapeutics Market on target to hit $153.2 billion by 2025: North America expected to remain dominant throughout the forecast period

03-20-2019 09:22 AM CET | Health & Medicine

Press release from: Allied Market Research

Autoimmune Disease Therapeutics Market

Autoimmune Disease Therapeutics Market

According to a new report released by Allied Market Research, the Global Autoimmune Disease Therapeutics Market has reached $ 109,833, and the "World Opportunity Analysis and Industry Outlook 2018-2025: Automobile Immune Disease Therapeutics Market by Classification, Display and Sales Channels" 2017 And is expected to grow at an average annual rate of 4.2% between 2018 and 2025, reaching $ 153.2 billion by 2025.

Anti-autoimmune disease drugs include anti-inflammatory drugs, antihyperglycemics, NSAIDs, interferons, immunosuppressants, corticosteroids, beta blockers and other types of drugs. Demand for autoimmune disease drugs is projected to increase during the forecast period due to the spread of autoimmune diseases, advances in screening and diagnostic procedures, and the broad availability of advanced therapeutics. Furthermore, the presence of pipeline drugs such as tocilizumab, barricinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab and tofacitinib is expected to further promote market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/5185

Depending on the drug type, the global autoimmune disease therapeutic market is classified as anti-inflammatory, antihyperglycemic, NSAID, interferon and others. Anti-inflammatory drugs were a major contributor to sales in 2017 and are anticipated to maintain dominance over the forecast period due to increased demand for anti-inflammatory drugs and the launch of the latest anti-inflammatory drugs through a supplemental reimbursement policy for the use of advanced anti-inflammatory drugs. The release of pipeline anti-inflammatory drugs such as tocilizumab, certolizumab, secukinumab, etanercept, golimumab and others is expected to affect market growth.

Depending on the indication, the market is classified as rheumatic disease, type 1 diabetes, multiple sclerosis, inflammatory bowel disease and other signs. Rheumatoid diseases accounted for a large proportion in 2017, and the duration of treatment is expected to be prolonged due to the high prevalence of arthritis, fibromyalgia, systemic lupus erythematosus, gout, scleroderma, and multiple myositis. Rheumatoid diseases, usefulness of advanced therapeutic agents for the treatment of these diseases.

According to the sales channel, the market is divided into hospital pharmacies, pharmacies and retail pharmacies, and online stores. Online services are expected to grow rapidly over the forecast period as online purchasing preference increases and the number of Internet users increases as more people become aware of online pharmacies than traditional methods. On the other hand, the pharmacy and retail pharmacy sectors are estimated to be major revenue contributors due to the large presence of these pharmacies.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/5185

Key Findings of the Autoimmune Disease Therapeutics Market:
• Based on indication, the rheumatic disease segment held nearly half of the global market share in 2017, and is projected to grow at a CAGR of 5.2% from 2018 to 2025.
• Based on sales channel, the online stores segment is expected to experience rapid growth and is projected to grow at a CAGR of 6.8% during the forecast period 2018-2025.
• Depending on drug class, the anti-inflammatory segment accounted for nearly half of the global market share in 2017, and is projected to grow at a CAGR of 5.2% from 2018 to 2025.
• Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.3% during the forecast period.

North America accounted for a major market share in 2017, and is expected to remain dominant throughout the forecast period. Higher prevalence of autoimmune disease, early diagnosis, easy availability of advanced therapeutics, strong presence of key players, favorable reimbursement in healthcare system, and higher number of trained medical professionals are key drivers of the North America autoimmune disease therapeutics market. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period owing to increase in number of target population, rise in adoption of therapeutics with development in healthcare infrastructure.

Access Full Summery @ https://www.alliedmarketresearch.com/autoimmune-disease-therapeutics-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Therapeutics Market on target to hit $153.2 billion by 2025: North America expected to remain dominant throughout the forecast period here

News-ID: 1663994 • Views: 206

More Releases from Allied Market Research

Envelope Tracking Chip Market Trends and Analysis (2021-2028): Top Impacting Fac …
Allied Market Research published a new report, titled, "Envelope Tracking Chip Market By Technology (Cellular Communications, Wireless Communications, and Satellite Communications), Application (Smart Phones, Wearable Devices, and Others), and End User (Consumer Electronics, Space and Aviation, Automotive, Telecommunications, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2028". The report provides a detailed study of the global envelope tracking chip market covering a number of important aspects such as current market scenario,
Enterprise Asset Leasing Market Growth Opportunities (2021-2028): Market Share a …
Allied Market Research published a new report, titled, "Enterprise Asset Leasing Market By Asset Type (Commercial Vehicles, Machinery & Industrial Equipment, Real Estate, IT Equipment and Others), Leasing Type (Operating Lease and Financial Lease), Industry Vertical (Transportation & Logistics, Manufacturing, Construction, IT & Telecom, Government & Public Sector and Others) and Enterprise Size (Large Enterprises and Small and Medium Enterprises): Global Opportunity Analysis and Industry Forecast, 2021-2028". The report provides a
High Performance Computing (HPC) Chipset Market Trends (2021-2028): Key Market D …
Allied Market Research published a new report, titled, "High Performance Computing (HPC) Chipset Market By Chip Type (CPU, GPU, FPGA, and ASIC): Global Opportunity Analysis and Industry Forecast, 2021-2028". The report provides a detailed study of the global HPC chipset market covering a number of important aspects such as current market scenario, estimates, top investment pockets, recent trends, changing dynamics, and vibrant forces of the industry from 2019 to 2028 to
Accelerometer and Gyroscope Market Current Updates (2021-2028): Growth Opportuni …
Allied Market Research published a new report, titled, "Accelerometer and Gyroscope Market By Type (Accelerometer and Gyroscope), Dimension (1-Axis, 2-Axis, and 3-Axis), and Industry Vertical (Consumer Electronics, Automotive, Aerospace & Defense, Industrial, and Healthcare) - Global Opportunity Analysis and Industry Forecast, 2020-2028". The report provides a detailed study of the global accelerometer and gyroscope market covering a number of important aspects such as current market scenario, estimates, top investment pockets, recent

All 5 Releases


More Releases for Disease

Infectious Disease Diagnostic Market
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques. The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased
Crohns Disease Treatment Market
Crohn’s disease is a chronic inflammatory bowel syndrome that causes inflammation in the gastrointestinal tract. Inflammation can take place anywhere between mouth to anus. It commonly affects end of small intestine (Ileum) and beginning of the colon. Common symptoms of Crohn’s disease from mild to severe intensity include abdominal pain, frequent diarrhea, reduced appetite, and fever. Sometimes rectal bleeding is also observed due to fissures from inflammation at anal canal.
Peyronie’s Disease Treatment Market
Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. This condition can cause painful erections and the penis gets bent while it is erected. The bent is towards the side where plaque is being formed i.e. either downwards or upwards. The condition is identified by a major bend or pain. In a few people
Global Gaucher Disease Treatment Market
Gaucher disease is recessive gene dominance disorder with massive clinical heterogeneity. Symptoms of the disease include painless splenomegaly, anemia, or thrombocytopenia, chronic fatigue, hepatomegaly, bone pain, and pathologic fractures. The disease also contributes to easy incidence of bruising and bleeding through the nose. Manifested in three sub-types, the disease results from the deficiency of the enzyme glucocerebrosidase. It is the most common lysosomal storage disorder and has an incidence of
Otava Alzheimer’s Disease Targeted Libraries
Alzheimer’s disease (AD) is a devastating and always fatal neurodegenerative disorder characterized by progressive impairment of cognitive function and emotional disturbances. Currently, more than 25 million people worldwide live with AD. But there is no cure for AD and no treatment to reverse its progression, there are medicines available that can help treat symptoms in some people with this disease. Intensive scientific research around the world brings us closer to
Cardiovascular Disease Prevention
Reduce Your Risk of Cardiovascular Disease… Useful information about how you can lower your blood pressure, lower cholesterol, and decrease your risk of heart disease. One person dies every 30 seconds from heart disease. That's over 2,600 people every single day!! Cardiovascular disease refers to any disorder in any of the various parts of your cardiovascular system, which includes your heart and blood vessels. The heart is the